Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giles Roditi

Showing results (111-120 of 121) with videos related to

Pageof 13
Sort By:
JACC. Cardiovascular Imaging|April 22, 2022
Pericoronary Adipose Tissue Attenuation, Low-Attenuation Plaque Burden, and 5-Year Risk of Myocardial InfarctionEvangelos Tzolos, Michelle C Williams, Priscilla McElhinney, et al.
Circulation|November 13, 2020
Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)Matthew M Y Lee, Katriona J M Brooksbank, Kirsty Wetherall, et al.
Circulation|January 27, 2023
Myocardial Involvement After Hospitalization for COVID-19 Complicated by Troponin Elevation: A Prospective, Multicenter, Observational StudyJessica Artico, Hunain Shiwani, James C Moon, et al.
European Radiology|September 9, 2020
Clinical pre-test probability for obstructive coronary artery disease: insights from the European DISCHARGE pilot studySarah Feger, Paolo Ibes, Adriane E Napp, et al.
JACC. Cardiovascular Imaging|August 29, 2024
Clinical Significance of Myocardial Injury in Patients Hospitalized for COVID-19: A Prospective, Multicenter, Cohort StudyHunain Shiwani, Jessica Artico, James C Moon, et al.
The International Journal of Cardiovascular Imaging|December 31, 2024
Myocardial ischaemia following COVID-19: a cardiovascular magnetic resonance studyJ Ranjit Arnold, Jian L Yeo, Charley A Budgeon, et al.
Circulation|July 25, 2022
Effect of Empagliflozin on Kidney Biochemical and Imaging Outcomes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure with Reduced Ejection Fraction (SUGAR-DM-HF)Matthew M Y Lee, Keith A Gillis, Katriona J M Brooksbank, et al.
Communications Medicine|February 28, 2024
Socioeconomic deprivation and illness trajectory in the Scottish population after COVID-19 hospitalizationAndrew J Morrow, Robert Sykes, Merna Saleh, et al.
Nature Medicine|May 23, 2022
A multisystem, cardio-renal investigation of post-COVID-19 illnessAndrew J Morrow, Robert Sykes, Alasdair McIntosh, et al.
European Radiology|November 20, 2016
Computed tomography versus invasive coronary angiography: design and methods of the pragmatic randomised multicentre DISCHARGE trialAdriane E Napp, Robert Haase, Michael Laule, et al.
Pageof 13

Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
JACC. Cardiovascular Imaging|April 22, 2022
Pericoronary Adipose Tissue Attenuation, Low-Attenuation Plaque Burden, and 5-Year Risk of Myocardial InfarctionEvangelos Tzolos, Michelle C Williams, Priscilla McElhinney, et al.
Circulation|November 13, 2020
Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)Matthew M Y Lee, Katriona J M Brooksbank, Kirsty Wetherall, et al.
Circulation|January 27, 2023
Myocardial Involvement After Hospitalization for COVID-19 Complicated by Troponin Elevation: A Prospective, Multicenter, Observational StudyJessica Artico, Hunain Shiwani, James C Moon, et al.
European Radiology|September 9, 2020
Clinical pre-test probability for obstructive coronary artery disease: insights from the European DISCHARGE pilot studySarah Feger, Paolo Ibes, Adriane E Napp, et al.
JACC. Cardiovascular Imaging|August 29, 2024
Clinical Significance of Myocardial Injury in Patients Hospitalized for COVID-19: A Prospective, Multicenter, Cohort StudyHunain Shiwani, Jessica Artico, James C Moon, et al.
The International Journal of Cardiovascular Imaging|December 31, 2024
Myocardial ischaemia following COVID-19: a cardiovascular magnetic resonance studyJ Ranjit Arnold, Jian L Yeo, Charley A Budgeon, et al.
Circulation|July 25, 2022
Effect of Empagliflozin on Kidney Biochemical and Imaging Outcomes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure with Reduced Ejection Fraction (SUGAR-DM-HF)Matthew M Y Lee, Keith A Gillis, Katriona J M Brooksbank, et al.
Communications Medicine|February 28, 2024
Socioeconomic deprivation and illness trajectory in the Scottish population after COVID-19 hospitalizationAndrew J Morrow, Robert Sykes, Merna Saleh, et al.
Nature Medicine|May 23, 2022
A multisystem, cardio-renal investigation of post-COVID-19 illnessAndrew J Morrow, Robert Sykes, Alasdair McIntosh, et al.
European Radiology|November 20, 2016
Computed tomography versus invasive coronary angiography: design and methods of the pragmatic randomised multicentre DISCHARGE trialAdriane E Napp, Robert Haase, Michael Laule, et al.
Pageof 13